Since we have demonstrated that IFNγ-producing T cells were increased in the spleen of APP−/− or APP+/+ mESC-TEP-treated AD mice (Figure 4E), we analyzed IFNγ availability at the CP in these mice. This evidence concerns the gene APP and Alzheimer disease.